Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-229
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.172 Human Genome Research
- 93.879 Medical Library Assistance
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- For Profit Organizations
- Other
- Public or Indian Housing Auth.
- County Governments
- Independent School Districts
- Small Businesses
- Special District Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- City/Township Governments
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- State Governments
- Non-501(c)(3) Nonprofits
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health seeks applicants for the Investigator Initiated Innovation in Computational Genomics and Data Science program (R21), with an application due date of September 4, 2026; clinical trials are not permitted. Eligible applicants include for-profit organizations, non-profits (501(c)(3) and non-501(c)(3)), higher education institutions (public and private), state and local governments, tribal governments (federally recognized and non-federally recognized), tribal organizations, county governments, independent school districts, special district governments, public or Indian housing authorities, and other entity types.
The program funds a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science. Supported activities include developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. All proposed work must address scalability to handle increasingly larger datasets and should be enabling for genomics and generalizable or broadly applicable across diseases and biological systems.
The opportunity is assigned to two parent grant programs: Medical Library Assistance (CFDA 93.879) and Human Genome Research (CFDA 93.172), both administered by the National Institutes of Health. Specific award ceilings, floors, expected number of awards, cost-share requirements, period of performance, place of performance, detailed evaluation criteria, and weighting are not specified in the source material. The source notes the FOA has expired per NOT-HS-26-002, indicating this opportunity may no longer be active.
Synopsis
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-229-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity